Home
Site Map
FAQs
Contact Us
Stock Quote
:
PWRM.OB
Investor Relations
Stock Quote / Details
Request Info
Financials
Recent News
Webcasts
SEC Filings
Insiders
Historical Quotes
Depth / level II
Stock Charts
Profile
Management Team
FAQ's
Recent News
Power3 Medical Files Two CIP Patent Applications for BC-SeraPro Breast Cancer Blood Test and Biomarkers
Nov 19 2008, 11:04 AM EST
Sun Health and Power3 Medical to Present Results of NuroPro(R) Alzheimer's Blood Test Clinical Validation Trial
Nov 7 2008, 10:55 AM EST
Power3 Medical Products in Collaboration with StemTroniX, Inc., to Identify and Monitor Autologous Adult Stem Cells for Use in Stem Cell Therapy using Protein Biomarkers
Oct 9 2008, 9:00 AM EDT
Power3 Medical Products in Talks with Industry Leaders to License and Market Its Proprietary Technology for Diagnostic, Disease Detection Blood Tests for Breast Cancer, Alzheimer's and Parkinson's Disease
Oct 7 2008, 10:00 AM EDT
Power3 Medical Products, Inc. Makes its Diagnostic Tests Ready for Commercialization
Oct 6 2008, 6:00 AM EDT
Power3 Medical's Dr. Ira Goldknopf to Present Invited Addresses in Philadelphia and Beijing in October 2008
Sep 24 2008, 8:00 AM EDT
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
Sep 12 2008, 9:40 AM EDT
Power3 Medical Products, Inc. Provides Progress Report - NuroPro(R) Clinical Validation Study of Serum Biomarkers for Alzheimer's Disease
Aug 13 2008, 8:30 AM EDT
Power3 Medical Products and the Princess Haya Biotechnology Center, Jordan University of Science and Technology, Collaborate in a Clinical Validation Study of the BC-SeraPro(TM) Breast Cancer Diagnostic Blood Test
Jul 15 2008, 10:49 AM EDT
Power3 Medical Products Advances the Diagnostic Capabilities of the Company's Alzheimer's Disease Biomarkers
Jul 10 2008, 9:30 AM EDT
1
2
3
4
............................................................................................................................................................................................................................................